William Blair Thinking
Stephanie Braming Named an Influential Woman in U.S. Finance
Stephanie Braming, CFA, Partner, Global Head of William Blair Investment Management, was named one of the 100 Most Influential Women in U.S. Finance by Barron’s for a third consecutive year.
Read moreWilliam Blair Private Capital Advisory: 2024 Secondary Market Report
The secondary market showed resilience in 2023, with overall volume increasing by 5% year-over-year despite macroeconomic challenges, and market insiders are bullish about prospects for 2024.
Read moreAviation Services Industry Update
A strong fourth quarter offered encouraging signs for business jet and general aviation’s continued recovery.
Read moreOur Mission, Vision, and Values
At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.
Learn more about our mission, vision, and valuesCommunity Engagement at William Blair
"Our job is to bridge the gap between those students who live in underserved communities and the financial industry. What William Blair has done has fully bought into our model of getting to know these young people, understanding their background, and understanding what we are trying to achieve. If not for William Blair, we would not be where we are today.”
Bevon Joseph, Co-Founder of Greenwood Project
Our Latest News
Charlesbank Capital Partners Has Acquired EverDriven Technologies
William Blair acted as the exclusive financial advisor to Charlesbank Capital Partners, in connection with its acquisition of EverDriven Technologies, a portfolio company of Palladium Equity Partners.
Read moreStephanie Braming Named an Influential Woman in U.S. Finance
Stephanie Braming, CFA, Partner, Global Head of William Blair Investment Management, was named one of the 100 Most Influential Women in U.S. Finance by Barron’s for a third consecutive year.
Read moreZevra Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Zevra Therapeutics, Inc. (ZVRA $6.10), a rare-disease therapeutics company.
Read moreJoin Our Team
Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.
Search our job openingsDelivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights